Induced Pluripotent Stem (iPS) Cell-Derived Differentiated Cells
Award Notice Posted
- Solicitation number
- 75N95023P00119NOTICE
- Agency
-
National Institute on Drug Abuse
National Institutes of Health, Department of Health and Human Services
- Awarded
- to Fujifilm Cellular Dynamics, Inc.
- Set-aside
- No set-aside
Opportunity facts
- Contract number
- 75N95023P00119 Federal contract award
- NAICS code
- 325414 Biological Product (except Diagnostic) Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Place of performance
- Madison, Wisconsin 53711, United States
Notice details come from SAM.gov. Updated .
About this opportunity
This Award Notice from the Department of Health and Human Services National Institutes of Health National Institute on Drug Abuse awarded a fixed price contract to Fujifilm Cellular Dynamics, Inc. for induced pluripotent stem (iPS) cell-derived differentiated cells. The non-competitively awarded contract valued at $583098.00 on February 23, 2023 was restricted to one source to ensure continuity of science and not change any variables that could skew results given the imperative to continue using the same vendor's cells going forward.
Notice text
The contract action was not awarded competitively. The contract action is fixed price.
It was awarded non-comptitively to keep uniform data going forward and not change any of the variables, thus skewing results, it is imperative to continue to use the same vendor’s cells. Therefore, to ensure the continuity of science, this acquisition is restricted to one source.
Awarded contract 75N95023P00119 to Fujifilm Cellular Dynamics, Inc. for 583098.00 on 2023-02-23.
Notice history
| Notice | Type | Posted |
|---|---|---|
| This notice | Award Notice | |
| Induced Pluripotent Stem (iPS) Cell-Derived Differentiated Cells | Solicitation |
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity